Pharmaceuticals News and Research

RSS

Strategic analysis of the breast cancer therapeutics pipeline

Strategic partnerships between the pharmaceuticals industry and the biotechnology sector are making breast cancer therapeutics one of the most dynamic segments in the overall oncology market.

15 Jul 2004

Computer-based program that assesses the health of people enrolled in a given health plan

Researchers at the Johns Hopkins Bloomberg School of Public Health have signed a multi-year agreement with PharMetrics, Inc., of Watertown, Mass., to acquire data from the company’s proprietary Anonymous Patient-Centric Database.

13 Jul 2004

AIDS Healthcare Foundation targets GSK over voluntary licensing of its AIDS drug patents in South Africa

At the international AIDS conference in Bangkok, AIDS Healthcare Foundation hosted a peaceful protest against British multinational pharmaceutical giant GlaxoSmithKline over its voluntary licensing of its AIDS drug patents in South Africa.

13 Jul 2004

How HIV/AIDS treatment can best be combined with community-based care in some of the poorest areas of sub-Saharan Africa

A West African community has joined the network of community-based treatment support programs that form Bristol-Myers Squibb's real world field test of how HIV/AIDS treatment can best be combined with community-based care in some of the poorest and most remote areas of sub-Saharan Africa.

13 Jul 2004

New guidelines for pulmonary arterial hypertension caution the use of calcium channel blockers

A new evidence-based guideline for pulmonary arterial hypertension (PAH) cautions the use of calcium channel blockers, a commonly used treatment for high blood pressure, in unstable patients due to the potentially fatal side effects associated with the medication.

13 Jul 2004

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).

12 Jul 2004

ATS receives a US $3.8 million order for a manufacturing system for new drug delivery technology

ATS Automation Tooling Systems Inc.has announced it has received a US $3.8 million (CDN $5.0 million) order from one of the world's largest pharmaceutical companies to provide a manufacturing system for a new drug delivery technology.

10 Jul 2004

Health Canada warning on Trazodone interaction with certain medications

Health Canada, in association with Bristol-Myers Squibb Canada, is advising Canadians to consult with their health care professionals if they are currently being treated with the antidepressant trazodone in combination with any of the following medications: ketoconazole (an antifungal agent), ritonavir and indinavir (protease inhibitors used in the treatment of HIV), or carbamazepine (an anti-epileptic therapy).

9 Jul 2004

Patient care violations at Sutter Solano Medical Center pose serious threats to the health and safety of patients

The Centers for Medicare and Medicaid, a federal agency within the U.S. Dept. of Health and Human Services, has concluded an investigation into patient care violations at Sutter Solano Medical Center that pose an “immediate and serious threat to the health and safety of patients.”

9 Jul 2004

Pfizer donates $3.7 million worth of Nicotrol patches to the New York City Department of Health

To help smokers quit, Pfizer is donating $3.7 million worth of eight-week courses of the Nicotrol patch, a leading nicotine replacement therapy (NRT), to the New York City Department of Health and Mental Hygiene (DOHMH).

9 Jul 2004

AIDS Healthcare Foundation, AIDS Therapeutic Treatment Now Coalition to unveil ambitious pledge at Bangkok 2004

Plans for advocacy, activism and protests throughout the weeklong AIDS conference to highlight the pressing need for increased access to life-saving anti-retroviral therapy (ARV) worldwide.

8 Jul 2004

Endo announces agreement With FDA for new trial design of oxymorphone extended-release tablets

Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc., today announced that it has reached agreement with the U.S. Food and Drug Administration

7 Jul 2004

Pfizer focuses on enabling America's 43 million uninsured to obtain medicines at significant savings

Pfizer Inc said today it will launch the pharmaceutical industry's most comprehensive initiative to significantly expand access to prescription medicines across the United States, with a specific focus on enabling America's 43 million uninsured to obtain Pfizer medicines at significant savings.

7 Jul 2004

Presidential Decree will have a direct negative impact on the health of millions of Ecuadorians

The international medical humanitarian organization Médecins Sans Frontières fears that a new Presidential Decree will make it much more difficult to obtain affordable essential medicines in Ecuador.

6 Jul 2004

Nanotechnology-based applications are accelerating the development of nanomedicine

With the potential for targeted therapy, and therefore reduced side effects, nanomedicine holds the promise of significantly improving quality of life parameters.

5 Jul 2004

Enzymes from king crab are an effective treatment for scalds, sores, and trophic ulcers

Chemist Galina Rudenskaya from the Moscow State University and her colleagues from small enterprise TRINITA have made an important discovery in medicine, thanks to funding extended by the RFBR and FASIE.

2 Jul 2004

Medicine storage temperatures are too high

The recommended maximum storage and transit temperatures for most medications is 25°C and are set by the pharmaceutical manufacturers.

2 Jul 2004

Gum disease vaccination aim of world-first research

Vaccinating people against gum disease will be the aim of world-first Melbourne research that today receives a $21.2 million boost from the Federal Government.

2 Jul 2004

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.

2 Jul 2004

No compulsory genetic testing for newborn babies in Europe

European Research Commissioner Philippe Busquin today rejected stories in several media claiming he had called for genetic testing of all newborn babies in Europe.

2 Jul 2004

Pharmaceuticals News and Research

Strategic analysis of the breast cancer therapeutics pipeline

Computer-based program that assesses the health of people enrolled in a given health plan

AIDS Healthcare Foundation targets GSK over voluntary licensing of its AIDS drug patents in South Africa

How HIV/AIDS treatment can best be combined with community-based care in some of the poorest areas of sub-Saharan Africa

New guidelines for pulmonary arterial hypertension caution the use of calcium channel blockers

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

ATS receives a US $3.8 million order for a manufacturing system for new drug delivery technology

Health Canada warning on Trazodone interaction with certain medications

Patient care violations at Sutter Solano Medical Center pose serious threats to the health and safety of patients

Pfizer donates $3.7 million worth of Nicotrol patches to the New York City Department of Health

AIDS Healthcare Foundation, AIDS Therapeutic Treatment Now Coalition to unveil ambitious pledge at Bangkok 2004

Endo announces agreement With FDA for new trial design of oxymorphone extended-release tablets

Pfizer focuses on enabling America's 43 million uninsured to obtain medicines at significant savings

Presidential Decree will have a direct negative impact on the health of millions of Ecuadorians

Nanotechnology-based applications are accelerating the development of nanomedicine

Enzymes from king crab are an effective treatment for scalds, sores, and trophic ulcers

Medicine storage temperatures are too high

Gum disease vaccination aim of world-first research

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

No compulsory genetic testing for newborn babies in Europe

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Uniting Against Resistance: The World Health Organization for World Antimicrobial Awareness Week 2023

Tackling Antimicrobial Resistance: A Conversation with Dr. Beverley Isherwood

Latest Life Science News